The U.S. Food and Drug Administration issued draft guidance aimed at helping developers bring gene therapies to patients more efficiently ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE